Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 9/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MDH1 | P40925 | 2/20 | 0.49 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.49 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.49 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.49 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.49 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.49 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.49 |
| ▸ | ACACB | O00763 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21656861 | 0.96 | MAPT (0.56) | LMNAOPRM1OPRD1OPRK1MAPT | |
| SCHEMBL21656682 | 0.95 | MAPT (0.55) | LMNAOPRM1OPRD1OPRK1MAPT | |
| SCHEMBL21656679 | 0.92 | LMNA (0.56) | LMNAOPRM1OPRD1OPRK1GRIN2D | |
| SCHEMBL21656688 | 0.89 | PDE4B (0.53) | LMNAOPRM1OPRD1OPRK1MAPT | |
| SCHEMBL21656974 | 0.88 | LMNA (0.60) | LMNAOPRM1OPRD1OPRK1MAPT | |
| SCHEMBL21656822 | 0.87 | GRM2 (0.57) | LMNAOPRM1OPRD1OPRK1MAPT | |
| SCHEMBL21628790 | 0.86 | OPRM1 (0.66) | OPRM1OPRD1OPRK1SMN1; SMN2GRIN2D | |
| SCHEMBL21628456 | 0.86 | OPRM1 (0.55) | OPRM1OPRD1OPRK1GRIN2DGRIN3B | |
| SCHEMBL21628606 | 0.86 | OPRM1 (0.67) | OPRM1OPRD1OPRK1GRIN2DGRIN3B | |
| SCHEMBL21656841 | 0.84 | CYP4A11 (0.64) | MAPTSMN1; SMN2MDH1CYP4A11CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2021-04-15 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | LMNA 3083/4885OPRM1 4075/4885OPRD1 3247/4885 |
| US-20210107863-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885OPRM1 3978/4885OPRD1 2899/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | LMNA 832/4885OPRM1 817/4885OPRD1 706/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | LMNA 3327/4885OPRM1 3978/4885OPRD1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.